Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000620205 | SCV000737153 | uncertain significance | Cardiovascular phenotype | 2016-09-01 | criteria provided, single submitter | clinical testing | The p.R262* variant (also known as c.784C>T), located in coding exon 7 of the NEXN gene, results from a C to T substitution at nucleotide position 784. This changes the amino acid from an arginine to a stop codon within coding exon 7. This variant was not reported in population-based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), Exome Aggregataion Consortium (ExAC), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 5942 samples (11884 alleles) with coverage at this position. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. However, loss of function of NEXN has not been clearly established as a mechanism of disease. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV001223312 | SCV001395454 | pathogenic | Dilated cardiomyopathy 1CC; Hypertrophic cardiomyopathy 20 | 2022-10-03 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 519122). This variant has not been reported in the literature in individuals affected with NEXN-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Arg262*) in the NEXN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEXN are known to be pathogenic (PMID: 32058062, 32814711, 32870709, 33949776). |
Fulgent Genetics, |
RCV001223312 | SCV002776484 | uncertain significance | Dilated cardiomyopathy 1CC; Hypertrophic cardiomyopathy 20 | 2021-11-18 | criteria provided, single submitter | clinical testing |